Evaluating the predictive value of endoscopic findings for residual colorectal cancer following neoadjuvant combination immunotherapy

Table 3 Presence of endoscopic findings before surgery in 17 mismatch repair deficient patients, n (%)

	Total (n = 17)	Residual disease (n = 3)	Complete response (n = 14)	P value
CR	2 (11.8)	0 (0)	2 (14.3)	0.67
NCR	4 (23.5)	1 (33.3)	3 (21.4)	0.58
PR	11 (64.7)	2 (66.7)	9 (64.3)	0.73

CR: Complete response; NCR: Near-complete response; PR: Partial response.